- Report
- March 2024
- 197 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2023
- 180 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- January 2022
- 115 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- April 2023
- 119 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- November 2021
- 270 Pages
Global
From €2402EUR$2,500USD£2,054GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more